Educating the medical device manufacturing industry since 2002.
Oxford BioDynamics’ announcement is based on results from a recently published multi-centre clinical study that confirms the efficacy of Oxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST)
By understanding and preparing for the potential impacts of geopolitical instability, medical device companies can enhance their resilience and continue to deliver critical healthcare solutions in an increasingly complex global...
Societal polarisation and its impact on the medical device development industry
Addressing the challenges posed by extreme weather events in the medical device development industry
Economic downturn: challenges and opportunities in the medical device development industry
Biodiversity loss and ecosystem collapse: the impact on the medical device development industry